Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
151.00    -0.40 (-0.26%)
Bid:
151.20
Ask:
152.00
Spread: 0.80 (0.529%)
Market Cap: £257.59m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Trading Update

30 Apr 2024 07:00

RNS Number : 4769M
McBride PLC
30 April 2024
 

30 April 2024

 

McBride plc

 

Trading Update

 

Continuing trading momentum from operational delivery and strong demand levels.Financial performance ahead of our expectations.

 

McBride plc (the "Group"), the leading European manufacturer and supplier of private label and contract manufactured products for the domestic household and professional cleaning and hygiene markets, today provides a trading update.

 

Strong operational performance combined with continued high demand levels for our high-quality private label products has meant Group trading in March and April has been ahead of our expectations.

 

For the first nine months of the current financial year, overall volumes were 6.5% higher than the prior year, with private label volumes growing by 9.7%. Group revenue was 8.2% higher than the prior year on a constant currency basis, benefitting from both volume growth and the impact of pricing actions in the last financial year to recover input cost inflation.

 

Input costs for chemicals and packaging remain at similar levels as at our last update in February 2024, with employment, general supplies and financing costs continuing to apply inflationary pressures. There are early signals that certain materials will see price rises as we progress into the second half of 2024, primarily in the more sustainable materials categories. Additionally, the Group continues to monitor and manage potential supply chain risks caused by heightened geopolitical tensions.

 

As a result of continuing strong trading performance, the Group now anticipates that adjusted operating profit will be c.10% ahead of current market expectations* and that net debt / adjusted EBITDA will be close to 1.6x by 30 June 2024.

 

The Group plans to issue a full year trading update on 16 July 2024.

 

* Group-compiled consensus of broker forecasts for FY24:

 

· Adjusted Operating Profit £61.0m

· Net Debt £132.0m

 

 

McBride plc

Chris Smith, Chief Executive Officer

Mark Strickland, Chief Financial Officer

Instinctif Partners

Guy Scarborough

Vivian Lai

0207 457 2020

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulations which came into effect on 3 July 2016.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKLFLZZLLBBL
Date   Source Headline
11th Sep 20205:00 pmRNSDirector/PDMR Shareholding
11th Sep 20205:00 pmRNSDirector/PDMR Shareholding
8th Sep 20207:00 amRNSFinal Results
1st Sep 20208:13 amRNSHolding(s) in Company
19th Aug 20207:00 amRNSHolding(s) in Company
14th Jul 20207:00 amRNSTrading update
26th Jun 20207:00 amRNSRedemption of B Shares
11th Jun 20207:00 amRNSDirectorate Change
19th May 20207:00 amRNSTrading Update
13th May 20204:35 pmRNSHolding(s) in Company
5th May 20205:00 pmRNSRedemption of B Shares
1st May 20207:00 amRNSChange in Remuneration Committee Responsibilities
28th Apr 20205:05 pmRNSDirector/PDMR Shareholding
25th Mar 20207:00 amRNSCOVID-19 Update
27th Feb 20205:00 pmRNSDirector/PDMR Shareholding
20th Feb 20207:00 amRNSHalf-year Report
16th Jan 20204:39 pmRNSHolding(s) in Company
14th Jan 20207:00 amRNSTrading Update
2nd Dec 20193:16 pmRNSIssue of B Shares as Part of the B Share Scheme
14th Nov 20197:00 amRNSDirectorate Change
6th Nov 20199:32 amRNSDirector/PDMR Shareholding
4th Nov 20194:00 pmRNSDirector/PDMR Shareholding
25th Oct 20193:57 pmRNSDirector/PDMR Shareholding
23rd Oct 20194:49 pmRNSResult of AGM
22nd Oct 20197:00 amRNSAGM Trading Update
15th Oct 20195:01 pmRNSTR1 Notification of major share holdings
8th Oct 20195:12 pmRNSDirector/PDMR Shareholding
8th Oct 20194:04 pmRNSDirector/PDMR Shareholding
8th Oct 20192:54 pmRNSDirector/PDMR Shareholding
7th Oct 20197:00 amRNSAppointment of Chairman Elect
4th Oct 20194:30 pmRNSDirector/PDMR Shareholding
4th Oct 20194:30 pmRNSHolding(s) in Company
4th Oct 20192:05 pmRNSAppointment of CEO and Chairman Succession
30th Sep 20194:12 pmRNSHolding(s) in Company
30th Sep 20194:05 pmRNSHolding(s) in Company
20th Sep 20194:00 pmRNSAnnual Report & Accounts & Notice of AGM
20th Sep 20194:00 pmRNSTotal Voting Rights
12th Sep 201911:06 amRNSDirector/PDMR Shareholding
5th Sep 20197:00 amRNSFinal Results
17th Jul 20193:18 pmRNSHolding(s) in Company
16th Jul 20194:25 pmRNSHolding(s) in Company
11th Jul 20197:00 amRNSTrading Update
26th Jun 20197:00 amRNSDirectorate Change
3rd Jun 20194:30 pmRNSIssue of B Shares as Part of the B Share Scheme
3rd Jun 20197:00 amRNSDirectorate Change
2nd May 20197:00 amRNSDirectorate Change and Trading Update
5th Apr 20192:23 pmRNSDirector/PDMR Shareholding
25th Mar 20194:38 pmRNSDirector Declaration
22nd Feb 201910:14 amRNSHolding(s) in Company
21st Feb 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.